When do athletes benefit from cardiac genetic testing?
- 1 August 2020
- journal article
- editorial
- Published by BMJ in British Journal of Sports Medicine
- Vol. 54 (15), 939-940
- https://doi.org/10.1136/bjsports-2020-101985
Abstract
Cardiac genetic testing is a valuable investigation for the diagnosis of over 40 cardiovascular diseases including the inherited cardiomyopathies and primary arrhythmogenic disorders. A positive genetic diagnosis can impact on the individual in terms of diagnosis, guiding treatment options and prognosis, as well as in screening family members. Advances in next generation sequencing technologies has resulted in the ability to test for panels of genes, quickly and at relatively low cost, making cardiac genetic testing more commonplace in clinical practice. Perhaps the greatest challenge is not the actual sequencing of cardiac genes but the detailed and comprehensive analysis and interpretation of the genetic data to determine the pathogenicity of the DNA variants identified and which of the findings are clinically relevant to the individual’s phenotype.1 As a result, cardiac genetic testing is best undertaken in a specialised multidisciplinary clinic setting where specific clinical and genetic expertise is available.2 3 In Australia and the UK, a referral to a specified cardiogenetics programme typically comes from a general cardiologist. These clinics are found in a number of …Funding Information
- National Health and Medical Research Council
This publication has 11 references indexed in Scilit:
- Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart AssociationCirculation: Genomic and Precision Medicine, 2019
- Outcomes of Cardiac Screening in Adolescent Soccer PlayersThe New England Journal of Medicine, 2018
- Management of young competitive athletes with cardiovascular conditionsHeart, 2016
- A Prospective Study of Sudden Cardiac Death among Children and Young AdultsThe New England Journal of Medicine, 2016
- Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease DetectionCirculation: Cardiovascular Genetics, 2015
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac ChannelopathiesJournal of the American College of Cardiology, 2015
- The value of cardiac genetic testingTrends in Cardiovascular Medicine, 2014
- HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia SyndromesHeart Rhythm, 2013
- Yield of Molecular and Clinical Testing for Arrhythmia SyndromesCirculation, 2013
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Heart Rhythm, 2011